Atossa Therapeutics Q2 EPS $(0.08) Down From $(0.05) YoY
Portfolio Pulse from Benzinga Newsdesk
Atossa Therapeutics reported Q2 losses of $(0.08) per share, a 60% increase from $(0.05) per share losses in the same period last year.
August 14, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Atossa Therapeutics reported a 60% increase in losses per share YoY in Q2.
Atossa Therapeutics reported a significant increase in losses per share for Q2, which is a negative indicator of the company's financial health. This could potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100